Your browser is no longer supported. Please, upgrade your browser.
DVAX Dynavax Technologies Corporation monthly Stock Chart
DVAX [NASD]
Dynavax Technologies Corporation
Index- P/E- EPS (ttm)-2.82 Insider Own0.20% Shs Outstand47.03M Perf Week24.70%
Market Cap486.76M Forward P/E- EPS next Y-1.39 Insider Trans6.81% Shs Float47.03M Perf Month86.49%
Income-110.70M PEG- EPS next Q-0.45 Inst Own62.90% Short Float12.30% Perf Quarter71.07%
Sales10.20M P/S47.72 EPS this Y10.10% Inst Trans12.21% Short Ratio4.00 Perf Half Y155.56%
Book/sh2.33 P/B4.44 EPS next Y2.80% ROA-84.10% Target Price10.00 Perf Year-25.38%
Cash/sh1.82 P/C5.70 EPS next 5Y- ROE-102.10% 52W Range3.20 - 17.50 Perf YTD162.03%
Dividend- P/FCF- EPS past 5Y5.50% ROI-124.10% 52W High-40.86% Beta1.52
Dividend %- Quick Ratio7.20 Sales past 5Y-12.60% Gross Margin- 52W Low223.44% ATR0.51
Employees251 Current Ratio7.20 Sales Q/Q-88.90% Oper. Margin- RSI (14)91.00 Volatility7.09% 7.06%
OptionableYes Debt/Eq0.00 EPS Q/Q13.90% Profit Margin- Rel Volume2.33 Prev Close9.95
ShortableYes LT Debt/Eq0.00 EarningsAug 07 BMO Payout- Avg Volume1.45M Price10.35
Recom2.30 SMA2039.21% SMA5063.79% SMA20057.44% Volume3,275,636 Change4.02%
May-09-17Reiterated RBC Capital Mkts Sector Perform $6 → $7
Apr-28-16Downgrade RBC Capital Mkts Outperform → Sector Perform $48 → $17
Apr-27-16Downgrade JP Morgan Overweight → Neutral
Nov-30-15Initiated RBC Capital Mkts Outperform $48
Nov-25-13Upgrade MLV & Co Hold → Buy $1.50 → $5
Feb-25-13Downgrade MLV & Co Buy → Hold
Nov-16-12Reiterated MLV & Co Buy $10 → $7.50
Jan-04-12Initiated MLV & Co Buy $8
Nov-09-10Reiterated Wedbush Outperform $6 → $8
Nov-08-10Initiated Jefferies Buy $4
May-13-10Upgrade Wedbush Neutral → Outperform $2.60 → $6
Mar-20-09Initiated Wedbush Morgan Buy $1.20
Oct-22-08Downgrade Oppenheimer Outperform → Perform
May-19-08Reiterated Susquehanna Financial Positive $7 → $5
May-19-08Downgrade Bear Stearns Outperform → Peer Perform
Mar-18-08Downgrade Merriman Curhan Ford Buy → Neutral
Feb-22-08Upgrade Oppenheimer Perform → Outperform $8.50
Oct-03-07Initiated Credit Suisse Outperform $8
Jun-06-07Initiated Susquehanna Financial Positive
Feb-26-07Downgrade JMP Securities Mkt Outperform → Mkt Perform
Jun-24-17 11:42AM  3 Stocks That Could Double Your Money Motley Fool
Jun-23-17 03:48PM  Lifshitz & Miller LLP Files Amended Shareholder Derivative Lawsuit on Behalf of Dynavax Technologies Corporation PR Newswire
Jun-21-17 08:30AM  Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance Business Wire +5.65%
08:20AM  Dynavax Technologies (DVAX) Catches Eye: Stock Gains 6.6% Zacks
Jun-06-17 08:15AM  Dynavax (DVAX) Looks Good: Stock Gains 16.9% in Session Zacks
08:00AM  Today's Research Reports on Stocks to Watch: Dynavax Technologies and Gigamon Accesswire
Jun-05-17 02:13PM  ETFs with exposure to Dynavax Technologies Corp. : June 5, 2017 Capital Cube +16.95%
12:17PM  Why Dynavax Technologies Corporation Stock Soared Today Motley Fool
Jun-02-17 04:01PM  Dynavax Presents Updated Data for SD-101 in Combination with KEYTRUDA(R) (pembrolizumab) Highlighting an ORR in 7 out of 7 Patients Naive to an Anti-PD-1 or Anti-PD-L1 Therapy Marketwired
May-31-17 07:06AM  3 Growth Stocks for Savvy Investors Motley Fool
May-30-17 08:00AM  Today's Research Reports on Stocks to Watch: AEterna Zentaris and Dynavax Technologies Accesswire
May-19-17 06:00AM  Dynavax to Present Data on SD-101 in Combination with KEYTRUDA(R) at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting Marketwired
May-11-17 04:31PM  ETFs with exposure to Dynavax Technologies Corp. : May 11, 2017 Capital Cube
May-10-17 10:35AM  Dynavax Technologies Corp. :DVAX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017 Capital Cube
May-08-17 06:06AM  Dynavax Technologies reports 1Q loss Associated Press
06:00AM  Dynavax Reports First Quarter 2017 Financial Results Marketwired
Apr-21-17 02:53PM  ETFs with exposure to Dynavax Technologies Corp. : April 21, 2017 Capital Cube
Apr-07-17 04:22PM  ETFs with exposure to Dynavax Technologies Corp. : April 7, 2017 Capital Cube
09:55AM  William Blair Assigns 70% Probability of Approval to Dynavax's Heplisav Investopedia
Apr-03-17 05:05PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
12:43PM  What Dynavax Technologies Holders Need to Consider Heading Into the Heplisav-B PDUFA GuruFocus.com
10:05AM  Why Dynavax Technologies Corporation Stock Briefly Spiked Today Motley Fool
10:05AM  Why Dynavax Technologies Corporation Stock Briefly Spiked Today at Motley Fool
06:00AM  Dynavax Announces FDA Advisory Committee Meeting to Review HEPLISAV-B Marketwired
Mar-27-17 03:55PM  ETFs with exposure to Dynavax Technologies Corp. : March 27, 2017 Capital Cube
03:55PM  ETFs with exposure to Dynavax Technologies Corp. : March 27, 2017
Mar-23-17 12:33PM  Dynavax Technologies Corp. :DVAX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 23, 2017 Capital Cube
12:33PM  Dynavax Technologies Corp. :DVAX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 23, 2017
10:45AM  Dynavax Technologies Corp. :DVAX-US: Earnings Analysis: 2016 By the Numbers : March 23, 2017
Mar-20-17 06:00AM  Dynavax Announces Upcoming Data Presentations for Three TLR9 Agonist Programs at the 2017 American Association for Cancer Research Annual Meeting Marketwired
Mar-17-17 01:04PM  DYNAVAX TECHNOLOGIES CORP Financials
Mar-13-17 04:34PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
04:19PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 10-K, Annual Report
06:14AM  Dynavax Technologies reports 4Q loss Associated Press
06:00AM  Dynavax Reports Fourth Quarter and Year End 2016 Financial Results and Company Update Marketwired
Mar-09-17 10:26AM  3 Beaten Down Stocks Ready to Bounce Back Motley Fool
10:26AM  3 Beaten Down Stocks Ready to Bounce Back at Motley Fool
Mar-08-17 12:40PM  [video]The 'Gnarly 9' Biotechs Will Test the FDA's Mettle
10:26AM  The 'Gnarly 9' Biotechs Will Test the FDA's Mettle
Mar-06-17 04:11PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
09:33AM  UPDATE: Dynavax shares reverse premarket losses to open flat at MarketWatch
08:00AM  Dynavax Presents Promising Clinical Data from Lead Immuno-Oncology Candidate, SD-101, at the International Congress on Targeted Anticancer Therapies Marketwired
Mar-02-17 09:30AM  Biotech's Outlook Strengthens After President Trump's Speech: Today's Reports on Dynavax Technologies and Lexicon Pharmaceuticals Accesswire -6.52%
06:00AM  Dynavax to Present at the Cowen and Company 37th Annual Health Care Conference Marketwired
Mar-01-17 03:47PM  Heres Whats Next For Lexicon Pharmaceuticals, Inc. (LXRX) And Dynavax Technologies Corporation (DVAX) at Insider Monkey +53.33%
02:58PM  Dynavax stock surges 53% on new FDA review of Hep B vaccine and Trump statements about FDA deregulation at MarketWatch
11:35AM  4 Biopharma Stocks Moving the Market on Wednesday
09:37AM  Why Dynavax Technologies Corporation Stock Is Skyrocketing Today at Motley Fool
Feb-28-17 05:02PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Stat
04:01PM  Dynavax Announces FDA Acceptance for Review of Its Complete Response to November 2016 CRL and PDUFA Action Date for HEPLISAV-B(TM) Marketwired
Feb-16-17 06:00AM  Dynavax to Present at the 2017 RBC Capital Markets Global Healthcare Conference Marketwired
Jan-27-17 09:20AM  Retired CEO of NBT Bancorp Inc. (NBTB) Offloads Shares, Plus Other Exciting Insider Trading at Insider Monkey
Jan-13-17 09:27PM  INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Dynavax Technologies Corporation and Encourages Investors with Losses to Contact the Firm Accesswire
04:13PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K/A, Costs Associated with Exit or Disposal Activities
11:09AM  SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Dynavax Technologies Corporation and Encourages Investors with Losses to Contact the Firm Accesswire
10:39AM  UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Shareholders of Dynavax Technologies Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2017 DVAX Business Wire
10:10AM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Dynavax Technologies Corporation (DVAX) and Lead Plaintiff Deadline: January 17, 2017 GlobeNewswire
Jan-12-17 06:10PM  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Dynavax Technologies Corporation and Encourages Investors with Losses to Contact the Firm Accesswire
Jan-11-17 11:27AM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Dynavax Technologies Corporation (DVAX) and Lead Plaintiff Deadline: January 17, 2017 Accesswire
Jan-09-17 12:39PM  DVAX SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Dynavax Technologies Corporation and a Lead Plaintiff Deadline of January 17, 2017 Business Wire
07:00AM  Dynavax to Present at J.P. Morgan 35th Annual Healthcare Conference Marketwired
Jan-07-17 06:00AM  DEADLINE ALERT: Brower Piven Reminds Investors Of The January 17, 2017 Deadline In Class Action Lawsuit And Encourages Investors With Losses In Excess of $100,000 From Investment In Dynavax Technologies Corporation To Contact The Firm Business Wire
Jan-06-17 03:06PM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Dynavax Technologies Corporation and Encourages Investors with Losses to Contact the Firm Accesswire
02:27PM  SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Dynavax Technologies Corporation and Encourages Investors with Losses to Contact the Firm Accesswire
10:25AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Dynavax Technologies Corporation (DVAX) and Lead Plaintiff Deadline: January 17, 2017 Accesswire
Jan-05-17 04:12PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial
01:51PM  Less is Not More for Biotech Investors at The Wall Street Journal
12:35PM  Dynavax Restructures and Emphasizes Immuno-Oncology Program Marketwired
Jan-03-17 03:38PM  EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Dynavax Technologies Corporation and Encourages Investors with Losses to Contact the Firm Accesswire
12:03PM  DVAX INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Dynavax Technologies Corporation and a Lead Plaintiff Deadline of January 17, 2017 PR Newswire
Jan-02-17 08:00AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Dynavax Technologies Corporation of Class Action Lawsuit and Upcoming Deadline DVAX GlobeNewswire
Dec-28-16 06:37PM  EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Dynavax Technologies Corporation and Encourages Investors with Losses to Contact the Firm Accesswire
03:43PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Dynavax Technologies Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2017 Business Wire
11:40AM  INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Dynavax Technologies Corporation and Encourages Investors with Losses to Contact the Firm Accesswire
10:23AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Dynavax Technologies Corporation (DVAX) and Lead Plaintiff Deadline: January 17, 2017 Accesswire
Dec-23-16 04:07PM  DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Termination of a Material Definitive Agreement
Dec-21-16 12:18PM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Dynavax Technologies Corporation and Encourages Investors with Losses to Contact the Firm Accesswire
10:33AM  DVAX SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Dynavax Technologies Corporation and a Lead Plaintiff Deadline of January 17, 2017 Business Wire
Dec-20-16 05:49PM  SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Dynavax Technologies Corporation and Encourages Investors with Losses to Contact the Firm Accesswire
02:05PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Dynavax Technologies Corporation To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit DVAX GlobeNewswire
02:01PM  SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Dynavax Technologies Corporation and Encourages Investors with Losses to Contact the Firm Accesswire
11:40AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Dynavax Technologies Corporation (DVAX) and Lead Plaintiff Deadline: January 17, 2017 Accesswire
08:45AM  Is the Options Market Predicting a Spike in Dynavax (DVAX) Stock?
Dec-19-16 04:30PM  INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Dynavax Technologies Corporation and Encourages Investors with Losses to Contact the Firm Accesswire
02:53PM  The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Dynavax Technologies Corporation Investors and Encourages Investors to Contact the Firm Business Wire
11:23AM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Dynavax Technologies Corporation and Encourages Investors with Losses to Contact the Firm Accesswire
Dec-18-16 07:35AM  Tax-Loss Selling: 3 Stocks to Dump Right Now at Motley Fool
Dec-16-16 08:03PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Dynavax Technologies Corporation of Class Action Lawsuit and Upcoming Deadline - DVAX Accesswire +7.32%
02:00PM  SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Dynavax Technologies Corporation and Encourages Investors with Losses to Contact the Firm Accesswire
11:15AM  DVAX INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Dynavax Technologies Corporation and a Lead Plaintiff Deadline of January 17, 2017 GlobeNewswire
Dec-14-16 12:58PM  ETFs with exposure to Dynavax Technologies Corp. : December 14, 2016
Dec-13-16 01:49PM  EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Dynavax Technologies Corporation and Encourages Investors with Losses to Contact the Firm Accesswire -7.87%
10:10AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Dynavax Technologies Corporation (DVAX) & Lead Plaintiff Deadline: January 17, 2017 GlobeNewswire
Dec-12-16 11:19AM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Dynavax Technologies Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2017 DVAX GlobeNewswire
Dec-11-16 09:15AM  On Deck Capital Inc (ONDK): Hedge Fund Sentiment Unchanged at Insider Monkey
Dec-10-16 07:32PM  Is Celldex Therapeutics, Inc. (CLDX) a Good Stock To Buy? at Insider Monkey
Dec-09-16 10:11PM  INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Dynavax Technologies Corporation and Encourages Investors with Losses to Contact the Firm Accesswire
08:12PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Dynavax Technologies Corporation of Class Action Lawsuit and Upcoming Deadline - DVAX Accesswire
Dec-07-16 03:18PM  SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Dynavax Technologies Corporation and Encourages Investors with Losses to Contact the Firm Accesswire
01:51PM  Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Dynavax Technologies Corporation Investors and Encourages Investors to Contact the Firm Business Wire
Dynavax Technologies Corporation, a clinical-stage immunotherapy company, focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor (TLR) stimulation. Its product candidates are being investigated for use in multiple cancer indications, as a vaccine for the prevention of hepatitis B and as a disease modifying therapy for asthma. The company's lead product candidates include HEPLISAV-B, an investigational adult hepatitis B vaccine, which is in Phase III clinical trials; and SD-101, an investigational cancer immunotherapeutic that is in Phase I/II studies. Its product candidates also comprise AZD1419, which is in Phase II clinical trial for the treatment of asthma; DV230F that is in preclinical stage for the treatment of liver tumors; and DV1001, a TLR 7&8 agonist, which is in preclinical stage for the treatment of for multiple malignancies, as well as DV281 for the treatment of non-small cell lung cancer. It has collaboration and license agreements with AstraZeneca AB to develop AZD1419 for the treatment of asthma; and Merck & Co. to develop SD-101 for varios immuno-oncology therapies. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was founded in 1996 and is headquartered in Berkeley, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
OSTRACH MICHAEL SSenior Vice PresidentMar 14Option Exercise0.0010,000018,772Mar 15 08:43 PM
Janssen RobertVice PresidentMar 14Option Exercise0.0010,000027,048Mar 15 08:40 PM
Novack David FSenior Vice PresidentMar 14Option Exercise0.0020,000022,121Mar 15 08:37 PM
Johnson David LouisVice PresidentFeb 05Option Exercise0.004,68804,688Feb 07 06:45 PM
Gray EddieCEO and DirectorFeb 04Option Exercise0.0050,000055,250Feb 07 06:47 PM
Janssen RobertVice PresidentJan 24Buy4.046,00024,24012,048Jan 26 07:11 PM
Janssen RobertVice PresidentJun 28Buy13.681,45219,8636,048Jun 30 06:51 AM